|
|
Other links at Articles > Medical Students |
| 1. |
SNJ-1656 Safely Lowers Intraocular Pressure in Healthy Volunteers
|
|
|
A phase I study of SNJ-1656, a selective Rho-associated coiled coil-forming protein kinase (ROCK) inhibitor, has shown the drug to be both safe and effective in lowering intraocular pressure (IOP) in healthy volunteers, according to a double-blind study reported by Japanese researchers in the March issue of the Archives of Ophthalmology. Reuters Health Information
|
| 3. |
Guidelines Issued for Cystic Fibrosis
|
|
|
Systematic and Cochrane reviews led to evidence-based recommendations regarding long-term use of medication for maintenance of lung function in patients with cystic fibrosis. Medscape Medical News
|
|
|
